
CALIX INC
CALXNYSE🏆 #1816 by market capEarnings Oct 27US Equity
$39.77▲ $0.15 (+0.38%)
Live1h▲ 0.0%
24h▲ 0.4%
7d▲ 3.4%
14d▲ 11.9%
30d▲ 0.1%
1y▼ 31.9%
🏦Market Cap
$2.50B
Small Cap
📈Revenue Growth (YoY)
+27.8%
High Growth
📊Gross Margin
56.6%
Healthy
💵FCF Margin
7.7%
Moderate
⚖️P/S Ratio
2.2x
Cheap
Otter Score
66
Fair
📊
Analyst Ratings
Price
$39.77
Total
21
Raised
4
Lowered
4
Avg PT
$57.00
H / L
$62 / $52
| Institution | Action | Rating | Date |
|---|---|---|---|
Rosenblatt | Reiterated | Buy | 2026-07-23 |
JP Morgan | Reiterated | Overweight | 2026-07-22 |
Northland Capital Markets | Upgraded | Market Perform → Outperform | 2026-07-21 |
Needham | Reiterated | Buy | 2026-04-23 |
Roth Capital | Reiterated | Buy | 2025-09-15 |
Craig-Hallum | Reiterated | Buy | 2024-07-24 |
Roth MKM | Reiterated | Buy | 2024-07-23 |
Jefferies | Downgraded | Buy → Hold | 2024-04-25 |
TD Cowen | Reiterated | Outperform | 2023-04-21 |
Loop Capital | Reiterated | Buy | 2023-01-27 |
Cowen & Co. | Reiterated | Outperform | 2022-07-27 |
Barrington Research | Reiterated | Outperform | 2022-07-27 |
BWS Financial | Reiterated | Sell | 2021-03-29 |
Northland Securities | Upgraded | Market Perform → Outperform | 2018-02-14 |
Stifel | Upgraded | Hold → Buy | 2016-01-08 |
Stifel Nicolaus | Upgraded | Hold → Buy | 2016-01-08 |
Morgan Stanley | Reiterated | Equal Weight | 2015-05-20 |
Goldman Sachs | Downgraded | Buy → Neutral | 2015-02-04 |
UBS | Downgraded | Buy → Neutral | 2015-02-04 |
Raymond James | Downgraded | Outperform → Market Perform | 2013-10-30 |
Evercore Partners | Reiterated | Overweight | 2013-05-24 |
One row per institution, most recent rating